2018 Agenda – Life Sciences Summit

Wednesday, October 24, 2018

View 2017 Agenda

7:45am-5:30pm	Registration
8:00am-8:45am	Pipeline Café Columbus Room
8:45am	Welcoming Remarks
9:00am-9:55am	Opening Plenary Session: Current Deal Trends in Mergers, Acquisitions, & Strategic Partnerships Columbus Room Moderator: Ellen B. Corenswet, Senior Counsel, Covington & Burling LLP Panelists: Neil Exter, MS, MBA, Partner, Third Rock Ventures Christine Fischette, PhD, Executive Director, Torreya Partners Skip Kelly, Head, Northeast Life Science & Healthcare, Silicon Valley Bank Dan Passeri, MSc, JD, President and Chief Executive Officer, Cue BioPharma Bavani Shankar, MBA, Senior Director, Business Development, Scientific Partnering & Alliances, AstraZeneca Deepa J. Talpade, PhD, MBA, Head, Primary Care and Specialty Transactions, Business Development and Licensing, MRL, Merck & Co., Inc.
10:00am-10:55am	Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies: What’s In, What’s Out, What’s Up-and-Coming Columbus Room Moderator: Jeffrey M. Bockman, PhD, Executive Vice President, Head of Oncology Practice, Defined Health Panelists: Michael Aberman, MD, MBA, President and CEO, Quentis Therapeutics, Inc. William Ho, MBA, Co-founder, President & CEO, Incysus Therapeutics, Inc. Christopher Mortko, PhD, Head, Headquarters Search and Evaluation, Merck Michael Quigley, PhD, Executive Director, Head – Oncology Discovery Biology, CA, Bristol-Myers Squibb Dmitriy Zamarin, MD, PhD, Assistant Attending Physician, Gynecologic Medical Oncology, Immunotherapetics Service, Memorial Sloan-Kettering Cancer Center
10:00am-11:00am	Emerging Company Showcase Tower Room 10:00am – Venarum Medical, LLC 10:15am – PainQx 10:30am – ZephyRx 10:45am – NoMo Diagnostics
10:00am-12:00pm	Partnering Forum
11:00am-11:55am	Business Workshop: Early Stage Financing: Novel Partnerships, Solutions, & Terms Columbus Room Moderator: Nicole McKnight, PhD, Managing Director, BioLabs New York Panelists: Stephen F. Flaim, PhD, FAHA, FACC, Director, Angel Capital Association, Chair Emeritus, Tech Coast Angels Board of Governors Sherry Grisewood, CFA, Senior Investment Officer, FoxHill Asset Management Gaurav Misra, MBA, Head, Greenfield BioVentures, Purdue Pharma Mike Pieck, PhD, Small Business Coordinator, National Heart, Lung, and Blood Institute Tony Stanco, Executive Director, National Council of Entrepreneurial Tech Transfer (NCET2) Tingting Zhang-Kharas, PhD, Advisor – Oncology External Innovation, Eli Lilly and Company
11:00am-12:00pm	Emerging Company Showcase Tower Room 11:00am – Allosteros Therapeutics, Inc. 11:15am – Avery Therapeutics, Inc. 11:30am – CardioCreate, Inc. 11:45am – Madeleine Pharmaceuticals, Inc.
12:00pm-1:05pm	Lunch with The Experts Columbus Room
12:00pm-1:05pm	Pipeline Café Columbus Room
1:15pm-2:10pm	Therapeutic Insight: Sepsis, a National Healthcare Crisis Columbus Room Moderator: Edward C. Saltzman, Executive Chairman, Defined Health Panelists: Timothy G. Buchman, PhD, MD, Special Advisor, Biomedical Advanced Research and Development Authority (BARDA) Clifford S. Deutschman, MS, MD, MCCM, Vice Chair, Research, Department of Pediatrics, Cohen Children’s Medical Center Anup Singh, Co-Founder & Chief Science Officer, InnaMed Inc. Orlaith Staunton, Co-Founder, The Rory Staunton Foundation
1:15pm-2:15pm	Emerging Company Showcase Tower Room 1:15pm – Kiromic, Inc. 1:30pm – CuronBiotech Inc 1:45pm – ADT Pharmaceuticals 2:00pm – AAVogen, Inc.
1:15pm-4:30pm	Partnering Forum
2:15pm-3:30pm	Emerging Company Showcase Tower Room 2:15pm – EpiVax Oncology 2:30pm – Celdara Medical 2:45pm – Global BioTherapeutics (GBT) 3:00pm – Rumi Scientific 3:15pm – Applied Immunotherapeutics
2:15pm-3:30pm	Emerging Company Showcase (Track 2) Columbus Room 2:15pm – PHD Biosciences 2:30pm – Rise Therapeutics 2:45pm – Goodwin & Wells 3:00pm – Intensity Therapeutics, Inc. 3:15pm – Aronora
3:30pm-4:25pm	Business Workshop: Diversity Through Leadership Columbus Room Moderator: Mia Jung, MBA, Partner, Oxeon Partners Panelists: Joanne M. Duncan, President, Membership & Business Operations, Biotechnology Innovation Organization (BIO) Rena Harper, MBA, Advisor, Human Resources, Lilly Research Laboratories, Eli Lilly and Company Sharon Klugewicz, MS, Senior Vice President, Chief Quality and Regulatory Officer, Chembio Diagnostic Systems, Inc. Minita Shah-Mara, MS, MBA, Head, Global Diversity and Inclusion, Biogen
3:30pm-4:30pm	Emerging Company Showcase Tower Room 3:30pm – Aegle Therapeutics 3:45pm – Elex Biotech 4:00pm – Trove Therapeutics, Inc. 4:15pm – DiamiR Biosciences
4:30pm-5:30pm	Plenary Session: Is It Too Early to Be Thinking IPO? Columbus Room Moderator: Lee Stettner, MBA, Managing Director, Solebury Capital Panelists: Isai Peimer, MBA, Biotech Analyst, Surveyor Capital (Citadel) Dennis J. Purcell, MBA, Founder and Senior Advisor, Aisling Capital LLC Maren Winnick, MBA, Managing Director, New York, Evercore Alex Zisson, Managing Director, H.I.G. Capital
5:30pm-7:00pm	Reception & Pipeline Café Sponsored by Sartorius Stedim North America Inc.

Thursday, October 25, 2018

8:00am-3:00pm	Registration
8:15am-9:00am	Pipeline Café Columbus Room
9:00am-9:55am	Plenary Session: US/China: Cross-Border Investment and Partnering Opportunities Columbus Room Moderator: Panelists: Xinxin Li, Director of Business Development, MyBioGate Inc. Michael Baran, PhD, MBA, Principal, Pfizer Ventures, Executive Director, External Science & Innovation, Oncology Research, Worldwide R&D, Pfizer, Inc Kimberly A. Nearing, Managing Director, Head of Life Sciences, Cedrus Group; Regional Leader, NY/NJ/PA Chapters, BayHelix Wyle Solomon, MS, MBA, Chief Executive Officer, iCell Gene Therapeutics Xiaodong(Eric) Wu, International Business Development Manager, Qilu Pharmaceutical Yan Zhang, PhD, Investment Director, Cowin Capital
10:00am-10:55am	Therapeutic Insight: “Metabesity” – A New Path for Drug Development in Metabolic Disease? Columbus Room Moderator: Danielle M. Marra, MS, MBA, Associate Principal, Defined Health Panelists: Chuck Gray, Director of Search and Evaluation, Global Drug Discovery, Novo Nordisk A/S Thomas C. Seoh, President & Chief Executive Officer, Kinexum Michael B. Zemel, PhD, Chief Scientific Officer, NuSirt Biopharma
10:00am-11:00am	Emerging Company Showcase Tower Room 10:00am – Windmill Cardiovascular Systems, Inc 10:15am – ColdSteel Laser 10:30am – Dendro Technologies (Formerly MyReLeaf ) 10:45am – Neurovation Labs
10:00am-12:00pm	Partnering Forum
11:00am-11:55am	Business Workshop: Decision Points in IP Strategy Columbus Room Moderator: Deborah A. Somerville, Partner, Fox Rothschild LLP Panelists: Laurence Blumberg, MD, President & CEO, Syntalogic Peter Donnelly, MS, MBA, Managing Director, Accelerate NY Seed Fund Craig S. Kenesky, PhD, Associate, Wilson, Sonsini, Goodrich & Rosati PC David S. Resnick, MS, Partner, Nixon Peabody
11:00am-12:00pm	Emerging Company Showcase Tower Room 11:00am – Neurovascular Diagnostics 11:15am – New York R&D Center for Translational Medicine and Therapeutics, Inc. (Ny.TmT) 11:30am – LiberaBio 11:45am – Novo Biosciences, Inc.
12:00pm-1:05pm	Lunch with The Experts Columbus Room
12:00pm-1:05pm	Pipeline Café Columbus Room
1:15pm-2:15pm	Strategic Partner Presentations Columbus Room
1:15pm-2:15pm	Emerging Company Showcase Tower Room 1:15pm – iCell Gene Therapeutics 1:30pm – Inhibikase Therapeutics, Inc. 1:45pm – Manhattan BioSolutions 2:00pm -Kures Inc
1:15pm-4:30pm	Partnering Forum
2:15pm-3:30pm	Emerging Company Showcase Tower Room 2:15pm – Forkhead BioTherapeutics Inc. 2:30pm – Glia LLC 2:45pm – Organix, Inc 3:00pm – Regenosine 3:15pm – Teclison
3:30pm-4:45pm	Closing Plenary Session & Reception: Corporate vs Private VC’s: The Differences and Similarities, and How They Impact Strategy Columbus Room Moderator: Joseph Gangitano, Associate, Covington & Burling LLP Panelists: Colleen Cuffaro, PhD, Principal, Canaan Jens Eckstein, PhD, President, SR One Sam Hall, PhD, Principal, Apple Tree Partners Alicia Iruzun-Lafitte, MBA, Principal, M Ventures, Merck KGaG Jonathan Mandelbaum, PhD, Principal, Accelerator Life Science Partners Denis Patrick, PhD, Vice President and Head, Oncology, External Science & Innovation and Innovative Medicines Initiative, Pfizer; Managing Partner, Pfizer Ventures

Plenary

KOLs

Workshops

Showcase